|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.159 HKD | +2.58% |
|
+1.92% | +41.96% |
| Feb. 23 | Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director | CI |
| 2023 | Aceso Life Science's Loss Widens in Fiscal H1 | MT |
Aceso Life Science Group Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was HKD 161 million compared to HKD 166 million a year ago. Net loss was HKD 51 million compared to HKD 83 million a year ago.
Basic loss per share from continuing operations was HKD 0.007 compared to HKD 0.0118 a year ago. Diluted loss per share from continuing operations was HKD 0.0071 compared to HKD 0.0163 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +41.96% | 150M | |
| +11.54% | 7.78B | |
| +12.00% | 4.47B | |
| -28.00% | 1.55B | |
| +9.61% | 872M | |
| +13.12% | 542M | |
| -21.40% | 510M | |
| -1.81% | 493M | |
| +12.09% | 312M | |
| -16.02% | 284M |
ACESO LIFE SCIENCE GROUP LIMITED 
